Galapagos has signed a deal to jettison its troubled JAK inhibitor drug Jyseleca, agreeing to sell the rights to rheumatoid arthritis and ulcerative colitis therapy to Italy’s Alfasigma SpA in a deal ...

Eli Lilly’s JAK inhibitor Olumiant has become the first drug in the JAK inhibitor class to be recommended for NHS use in England and Wales as a treatment for atopic dermatitis, also known as eczema.

A large clinical cohort study of adult patients taking JAK inhibitors for atopic dermatitis has found that they have more than twice the risk of developing acne at 6 months than patients taking Th2 ...

American driver Jak Crawford will be Aston Martin's third driver for the 2026 Formula 1 season, effectively acting as reserve to Fernando Alonso and Lance Stroll should either be unable to race.

AUSTIN -- Rising American racing star Jak Crawford will drive in first practice for Aston Martin ahead of Formula 1's Mexico City Grand Prix next week. Crawford, 20, will take Lance Stroll's seat in ...

NEW YORK CITY — When data from clinical trials of JAK inhibitors in atopic dermatitis (AD), vitiligo, and other skin diseases are stratified by race, response rates appear to diverge, with both higher ...

Please provide your email address to receive an email when new articles are posted on . JAK inhibition carried higher malignancy risk vs. biologic DMARDs. Malignancy risk was seen in older patients ...

Moises Mendez II is an associate editor at Out Magazine based in Brooklyn, New York. He covers internet culture and entertainment, including television, movies, music, and more. Before joining Out, he ...

English actor Jak Malone delivered a powerful message about accepting transgender people for who they are during the 2025 Tony Awards. Malone took the stage at Radio City Music Hall in New York City ...

For Jak Malone, being a dedicated fan pays off. “I knew that some of my favorite writers were making a musical,” says the 31-year-old actor, nominated for a Tony Award for Best Actor in a Featured ...

Ruxolitinib cream shows comparable efficacy to systemic therapies in reducing disease severity in moderate atopic dermatitis, with significant BSA reduction over 7.4 months. Abrocitinib demonstrates ...

Janus kinase inhibitors (JAKis) are an important treatment option for people with chronic inflammatory diseases such as rheumatoid arthritis, psoriasis, Crohn's disease or ulcerative colitis. Since ...